Overview: Functional programming prevents unintended data changes, reducing errors in large systems.Pure functions improve testing accuracy because outputs depe ...

Applications are now open for the 2026 American Fidelity STEM Teacher Fellowship! It’s hard for me to think of why ...

This productive discussion with FDA reviewers gives Ernest leadership renewed confidence our development plan is on the ...

North Shore Collinwood has been the place I’ve called home for over two decades. In that time, I’ve seen the excitement of the Collinwood Recreation Center being built, the energy of the Waterloo Arts ...

Modular electric guitars are the future of the iconic instrument We're coming up on the 100th anniversary of the electric guitar, and it's been fascinating to hear how this simple instrument has ...

If you’ve ever used a 3D printer, you may recall the wondrous feeling when you first printed something you could have never sculpted or built yourself. Download a model file, load some plastic ...

The group of preteens uncapped their markers and began practicing how to capitalize two new letters: “B” and “Q.” The lesson felt like a return to the basics. Only this time, the middle-schoolers were ...

AI coding agents from OpenAI, Anthropic, and Google can now work on software projects for hours at a time, writing complete apps, running tests, and fixing bugs with human supervision. But these tools ...

This is read by an automated voice. Please report any issues or inconsistencies here. A retired couple’s ADU in Harbor Gateway took just 3½ months to build, the fastest to date for Los Angeles-based ...

The federal government is sending the nation's largest public utility a $400 million grant to propel the development of an advanced nuclear reactor in East Tennessee as power demand rises. The ...

If only they were robotic! Instead, chatbots have developed a distinctive — and grating — voice. Credit...Illustration by Giacomo Gambineri Supported by By Sam Kriss In the quiet hum of our digital ...

Regeneron is adding its name to Tessera Therapeutics’ unique in vivo gene-writing program, inking a deal that lets it in on a prospect for alpha-1 antitrypsin deficiency (AATD) through a $150 million ...